×
About 1,813 results

ALLMedicine™ Pituitary Tumors Center

Research & Reviews  629 results

Corticotrophin-releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing s Disease
https://clinicaltrials.gov/ct2/show/NCT04569591

Jun 24th, 2022 - This study is designed as a single institution trial. The study utilizes safe and clinically-validated tools for preoperative workup of patients with small pituitary tumors. CRH stimulation and 18F-FDG uptake in PET imaging will be used to detect ...

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
https://clinicaltrials.gov/ct2/show/NCT00001595

Jun 24th, 2022 - Study Description: This protocol aims to evaluate subjects with tumors of the hypothalamic pituitary unit to: identify genetic components of pituitary and hypothalamic oncogenesis, to develop new clinical studies for the recognition and thera...

SIRT1 suppresses pituitary tumor progression by downregulating PTTG1 expression.
https://doi.org/10.3892/or.2022.8354
Oncology Reports; Huang J, Zhang F et. al.

Jun 23rd, 2022 - Although pituitary tumors are among the most common types of brain tumor, the underlying molecular mechanism of this disease remains obscure. To this end, the role of sirtuin 1 (SIRT1) in pituitary tumors was reported. The results of reverse trans...

Growth Hormone Deficiency in Adults
http://emedicine.medscape.com/article/120767-overview

Jun 17th, 2022 - Background The somatotroph cells of the anterior pituitary gland produce growth hormone (GH), which is stimulated by GH-releasing hormone (GHRH) and inhibited by somatostatin, both of which are produced by the hypothalamus. Adult GH deficiency can...

see more →

Guidelines  3 results

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Pre...
https://doi.org/10.1227/NEU.0000000000001388
Neurosurgery Newman SA, Turbin RE et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are the most frequent pituitary tumors. Visual symptoms from NFPAs are common and include visual field defects, loss of central vision, and motility problems resulting in diplopia. To create evidence-based...

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on th...
https://doi.org/10.1227/NEU.0000000000001386
Neurosurgery Aghi MK, Chen CC et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are the most frequent pituitary tumors. To create evidence-based guidelines for the initial management of NFPAs. A multidisciplinary task force composed of physician volunteers and evidence-based medicine-...

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Pos...
https://doi.org/10.1227/NEU.0000000000001392
Neurosurgery Ziu M, Dunn IF et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are the most frequent pituitary tumors. Due to the lack of hormonal hypersecretion, posttreatment follow-up evaluation of NFPAs is challenging. To create evidence-based guidelines in an attempt to formulat...

see more →

Drugs  14 results see all →

Clinicaltrials.gov  39 results

Corticotrophin-releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing s Disease
https://clinicaltrials.gov/ct2/show/NCT04569591

Jun 24th, 2022 - This study is designed as a single institution trial. The study utilizes safe and clinically-validated tools for preoperative workup of patients with small pituitary tumors. CRH stimulation and 18F-FDG uptake in PET imaging will be used to detect ...

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
https://clinicaltrials.gov/ct2/show/NCT00001595

Jun 24th, 2022 - Study Description: This protocol aims to evaluate subjects with tumors of the hypothalamic pituitary unit to: identify genetic components of pituitary and hypothalamic oncogenesis, to develop new clinical studies for the recognition and thera...

Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
https://clinicaltrials.gov/ct2/show/NCT04042753

May 19th, 2022 - The purpose of this study is to determine if nivolumab and ipilimumab are effective treatment for people with pituitary tumors have gotten worse after surgery and radiation.

Nasal Packing Following Endoscopic Endonasal Pituitary Resection
https://clinicaltrials.gov/ct2/show/NCT03677713

Apr 20th, 2022 - BACKGROUND AND CLINICAL SIGNIFICANCE Over the past decade, the surgical method for removing pituitary tumors has shifted from a microscopic resection technique performed exclusively by a neurosurgeon, to an endoscopic resection done as a team with...

Ga-68-DOTATOC -PET in the Management of Pituitary Tumours
https://clinicaltrials.gov/ct2/show/NCT02419664

Mar 31st, 2022 - Background The most common cause to pituitary insufficiency is the pituitary adenoma (PA). PA may be divided into hormone producing PAs and non-functioning PAs (NFPA). Normal pituitary tissue, as well as tissues from PAs, expresses somatostatin re...

see more →

News  27 results

Don't Use Growth Hormone for Anti-Aging, Say New Guidelines
https://www.staging.medscape.com/viewarticle/922195

Dec 5th, 2019 - The 2019 Guidelines for Management of Growth Hormone Deficiency in Adults and Patients Transitioning from Pediatric to Adult Care issued by two key US endocrine societies cover important developments in the decade since the previous version.   The...

Prolactin, the pituitary, and pregnancy: Where’s the balance?
https://www.mdedge.com/obgyn/article/164370/pituitary-thyroid-adrenal-disorders/prolactin-pituitary-and-pregnancy-wheres
Kari Oakes

Apr 26th, 2018 - CHICAGO – Management of fertility and reproduction for women with prolactin-secreting pituitary tumors is a balancing act, often in the absence of robust data to support clinical decision making. So judgment, communication, and paying attention to.

Clinical Guidelines: Testosterone therapy in men with hypogonadism
https://www.mdedge.com/familymedicine/article/163830/mens-health/clinical-guidelines-testosterone-therapy-men-hypogonadism
Family Practice News; Neil Skolnik, MD, Michael Hurchick, DO

Apr 19th, 2018 - Guidelines issued jointly by the Endocrine Society and the European Society for Endocrinology provide clinicians with a clear consensus approach to male hypogonadism, commonly referred to by patients as “low T. ” Hypogonadism results from “the fail.

New Clinical Practice Guidelines, November 2017
https://reference.medscape.com/viewarticle/888107_10

Nov 8th, 2017 - Pituitary Tumors and Carcinomas European Society of Endocrinology Recommend all pituitary tumors undergo histopathologic analysis, which should include, at a minimum, immunodetection of pituitary hormones and Ki-67 proliferative index evaluation. ...

Temozolomide may help half of patients with aggressive pituitary tumors
https://www.mdedge.com/endocrinology/article/134819/endocrine-cancer/temozolomide-may-help-half-patients-aggressive
Michele G. Sullivan

Apr 2nd, 2017 - ORLANDO – Temozolomide, an alkylating agent approved for glioblastoma, improved long-term survival in about half of patients who took it for aggressive pituitary tumors, a retrospective study has determined. The study, conducted by members of the.

see more →

Patient Education  13 results see all →